Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Aggressive False Claims Actions, Medical Necessity Determinations and Individual Liability Charges

Events

July 31, 2012

Bass, Berry & Sims healthcare fraud attorney, Anna Grizzle, will participate on the panel discussion, "Aggressive False Claims Actions, Medical Necessity Determinations and Individual Liability Charges" at the American Conference Institute's Advanced Forum on Healthcare Provider Disputes and Litigation on Tuesday, July 31. Assistant United States Attorney, Jeffrey W. Dickstein, will also participate in this panel discussion.

The topic of discussion will cover:

  • Minimizing your exposure to False Claims Act violations under Health Care Reform's expanded statute
  • Examining the key considerations, strategies and timing involved in the motion practice and procedural issues when it becomes necessary to litigate a FCA case
  • Ensuring diagnosis codes are properly submitted so that the provider is reimbursed for services offered
  • Reporting overpayments to the government within a defined period of time to avoid increased monetary penalties
  • Top 5 things to do now to diminish your risk of a government investigation
  • Developing a risk adjustment model that withstands government scrutiny billing, medical necessity, and other fraud.
  • Determining if a procedure was medically necessary and who authorized its performance
  • Mitigating the risks of billing for services not provided, billing for a level of service not provided, or miscoding a claim to obtain reimbursement
  • Conducting due diligence assessments to safeguard the provider against anti-kickback and Stark Law violations Individual Accountability
  • Working through available defenses to a Park charge
  • Insulating yourself from liability in the government's pursuit of individual providers for health care fraud
  • Preparing for the government’s increased focus on provider activity
  • Ensuring that service was provided within Medicare guidelines
  • Learning how to cope with corporate life under the government's microscope
  • Representing yourself accurately and producing documents to avoid false claims or obstruction of justice allegations
Download Document - ACI Healthcare Provider Disputes and Litigation Conference Brochure

Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.